Catalyst Wire Dossier Catalyst Wire Dossier

IgE-specific immunoadsorption (IGEIAAD)

IgE immunoadsorption
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IgE-specific immunoadsorption (IGEIAAD), covering 2024-07-15 to 2024-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD) [Phase 2]

See pricing